Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Ethyl p-Hydroxybenzoate in Pharmaceuticals

A technology of ethyl p-hydroxybenzoate and ethyl hydroxybenzoate, applied in the new application field of ethyl p-hydroxybenzoate in pharmaceuticals, to achieve the effect of lowering blood pressure, improving urinary protein, and reducing the level of oxidative stress in endothelial cells

Active Publication Date: 2018-01-26
广州康臣药业有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is used as a bacteriostatic preservative in pharmaceuticals, widely used in liquid preparations and semi-solid preparations; it has similar uses in the food industry and daily chemical industry, and is widely used in the preservation of food and cosmetics, but its role in diabetic nephropathy drugs application, not yet reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Ethyl p-Hydroxybenzoate in Pharmaceuticals
  • Application of Ethyl p-Hydroxybenzoate in Pharmaceuticals
  • Application of Ethyl p-Hydroxybenzoate in Pharmaceuticals

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] The preparation of embodiment 1 ethyl p-hydroxybenzoate

[0032] References (Liu Jing, Wang Yunfang. Synthesis of ethyl p-hydroxybenzoate. Journal of Weinan Normal University 2005,20(5):5-7) synthesized ethyl p-hydroxybenzoate.

[0033] Add 0.05mol (6.9g) p-hydroxybenzoic acid, 0.2mol (11.65ml) ethanol and 0.017mol (1.66g) catalyst to a three-necked flask equipped with an electric stirrer, a thermometer, and a reflux device with a water separator Sulfamic acid was heated to reflux for 3 hours, the catalyst was filtered out while it was hot, and the raffinate was quickly poured into cold water, and the solid crude product was precipitated from the water. Filtration, the filter cake was washed with 5% Na 2 CO 3 Wash with aqueous solution and water, and dry to obtain crude product. In a round bottom flask equipped with a reflux condenser, add the crude product of ethyl p-hydroxybenzoate, ethanol, water and 0.1% activated carbon at a molar ratio of 1:4:0.5, heat to reflu...

Embodiment 2

[0034] The preparation of embodiment 2 ethyl p-hydroxybenzoate granules

[0035] Each packet of granules contains the following components:

[0036] Ethylparaben 5mg

[0037] Starch 2497.5mg

[0038] Microcrystalline Cellulose 2497.5mg

[0039] The preparation method is as follows: pass ethyl p-hydroxybenzoate through 80-mesh sieve, mix evenly with starch and microcrystalline cellulose, use appropriate amount of water to make soft material, granulate, dry, granulate, and pack.

Embodiment 3

[0040] Embodiment 3 Preparation of ethyl p-hydroxybenzoate tablet

[0041] Each tablet contains the following ingredients:

[0042]

[0043] The preparation method is as follows: pass ethyl p-hydroxybenzoate through a 80-mesh sieve, mix evenly with lactose and cornstarch, add appropriate amount of water and granulate the powder, after drying, sieve the granules and mix with magnesium stearate, Tablets are available.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a new application of ethyl p-hydroxybenzoate in pharmacy and belongs to the field of medicine. Ethyl p-hydroxybenzoate has preventive and therapeutic effects on diabetic nephropathy, can inhibit the proliferation of glomerular mesangial cells and apoptosis of endothelial cells induced by AGEs, reduce the level of oxidative stress of endothelial cells induced by AGEs, and improve STZ‑CFA The urine protein, urine creatinine, serum creatinine, creatinine clearance rate, blood sugar and blood pressure of diabetic nephropathy model rats caused by diabetes were abnormal. Ethyl p-hydroxybenzoate can be prepared into a pharmaceutical composition with a drug carrier, and then prepared into various oral dosage forms, such as granules, tablets, capsules, pills, etc., which are easy to use, safe and reliable.

Description

technical field [0001] The invention relates to the field of medicine, in particular to the new application of ethyl p-hydroxybenzoate in pharmacy. Background technique [0002] Diabetes and its complications have seriously affected human health and quality of life. As of 2004, 3.4 million people had died from diabetes and its complications, and the World Health Organization predicts that this number will double between 2005 and 2030. Diabetic nephropathy is one of the most common and serious chronic microvascular complications of diabetes, and is the leading cause of death in diabetic patients. According to the data of the World Health Organization, if blood sugar is not controlled, about 30% of patients with type 1 diabetes and 25%-40% of patients with type 2 diabetes will develop diabetic nephropathy. Therefore, it is of great significance to actively seek effective measures to prevent and treat diabetic nephropathy. Clinically, diabetic nephropathy mainly manifests as...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/235A61P13/12
Inventor 何宝郑兆广朱奎石兴华段婷婷王汝上杨琳琳陈丹扬胡琴高雪晖顾斐程慧奎高俊飞杨丹屈夏菁
Owner 广州康臣药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com